Nutrafol’s latest product ushers the brand into new (hair care) territory. And it’s a terrific option for guys with short ...
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Hims & Hers Health shares swooned after the Food & Drug Administration said the active ingredient in Ozempic and Wegovy is no ...
The move comes as the S&P 500 lost 1% and the Nasdaq Composite lost 1.3%. Hims & Hers, one of the most popular telehealth services in the world, is in danger of losing one of its central revenue ...
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
Delhi's new BJP-led administration announced a significant healthcare reform strategy, addressing staffing shortages, ...
Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...
Hims & Hers bought an at-home lab testing company as it branches out into other clinical areas beyond its recent ...
Hims & Hers Health (HIMS) is jumping 15% after the company announced that it had made an acquisition which will allow it to ...
The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...
Stock futures rise as traders eye Fed minutes and tariffs. Tesla, Intel, and Buffett-backed Constellation lead pre-market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback